RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages
about
Immune signaling by RIG-I-like receptorsCytokine synergy: an underappreciated contributor to innate anti-viral immunityInnate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasomeMyxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeletonCombined genome-wide expression profiling and targeted RNA interference in primary mouse macrophages reveals perturbation of transcriptional networks associated with interferon signallingCoordinated regulation of SIV replication and immune responses in the CNS.Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha responseOncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virusPotent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domainAblation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infectionA whole-genome RNA interference screen for human cell factors affecting myxoma virus replicationImproving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling PathwaysPositive evolutionary selection on the RIG-I-like receptor genes in mammalsHuman cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-beta.Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.Oncolytic virotherapy for hematological malignancies.An overview of the lagomorph immune system and its genetic diversity.Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome.Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways.Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovisInosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8.Cytokine determinants of viral tropism.Myxoma Virus dsRNA Binding Protein M029 Inhibits the Type I IFN-Induced Antiviral State in a Highly Species-Specific Fashion.Modulation of the host immune response by cowpox virusThe immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.Virus inhibition of RIP3-dependent necrosis.Bovine herpesvirus type 1 as a novel oncolytic virus.Mitochondrial antiviral signaling protein plays a major role in induction of the fish innate immune response against RNA and DNA viruses.Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model.Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells.Combinatorial cytokine code generates anti-viral state in dendritic cells.Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized.Evolution of viral sensing RIG-I-like receptor genes in Leporidae genera Oryctolagus, Sylvilagus, and Lepus.The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts.Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells.Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.
P2860
Q24304438-C01BDD2E-AFE9-4BD5-ACF3-B1EE1CA2B67AQ26852421-C16267BF-74DF-4499-A374-174E490ECEC3Q28389050-44554B61-929F-42E4-9407-957BEDCA3269Q28538172-115FC935-41F0-4B61-929A-3B27F9F6778DQ33491870-F8AA7D19-70DD-4CDC-8C48-0CBE53295400Q33519523-50D116B1-2A4C-4416-B363-3730F5420C7EQ33598425-5F6F5B1C-9D73-4041-8861-5D5E2914910AQ33895494-A662B171-F80C-4E65-8693-E5BB6C3E9027Q33931640-B73C9407-E3A1-4905-A026-A9F875771FD5Q34150344-B7D4711F-AFB2-4563-82EF-999A0BA15457Q34273718-1B85104D-F4C0-4105-8AB2-AF52B943061EQ34404551-8CA5C583-2036-44C9-B6CE-88A6371788B0Q34585582-D9DBA24B-B5D6-42B7-833A-1D4902041F56Q34796206-82C7D39D-BF61-4156-ABCF-0BC1C1E66B0AQ35060758-0973D528-05DD-46A6-B707-5990274DAC94Q35223463-F0B2DC06-78B7-4427-9BC5-849C97628848Q35274869-76AF39FC-E6AF-409D-8608-8A08FBB2BEB5Q35692095-75132BE4-839A-4545-8761-8249FF462954Q35785529-2C8D9667-ACF0-407F-9194-A7A5C65A2114Q37069062-7392463F-2917-4986-A32D-5799CA2B3767Q37232811-EEF8E8A2-9FFD-49EA-B29B-C61F6F26484DQ37333955-B3A0A20F-3EE7-49F4-A028-088684B03BE9Q37547499-365F31F6-67EE-4859-A021-6598AABFFA47Q37583568-EF071FF0-00DF-42BD-82E9-6D694E036D3CQ37676089-9C2AC0B2-CE45-4AA8-B6E5-33607E55136AQ37776790-2F9CBA23-AAFB-4442-BBA4-BF8C8C9611A0Q37787452-52DB85CE-D208-442B-BEAF-4915DC58B615Q38961205-4B3BA80A-E449-4C4E-B94D-44C3FA19B80AQ39603352-F9CC1DCB-3877-4D42-A9AD-26CBFACFD679Q39711744-16AF4A24-9480-4C36-A9C7-21563E692AE9Q39778474-F583072E-6840-46DC-9D75-9186BE7E6E71Q39846411-1C7FBF3C-C105-4E95-BC9E-77DD69AF43D2Q40056618-F36C1C83-EA4E-47F5-BEC3-3E83C13C5A4EQ41052462-D25B75AF-33E3-4AA7-A66C-6FA4F34AFC36Q41979482-678BA559-C7AD-4B5E-8CA3-FA99A799D717Q41988706-6C29B1DF-6C0F-442D-A9BC-65987601354FQ42256141-B2CEBC12-1DD6-48D1-B0EF-5F1A29BA0FE4Q43215263-F67BCF03-CC83-47D5-A583-21D6CC6B3AF7Q44837303-7710B94A-B92E-4006-998E-74E8FDED17B5Q47555333-DB890605-67C6-4239-BB75-54BC29DBD070
P2860
RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
RIG-I mediates the co-inductio ...... s in primary human macrophages
@ast
RIG-I mediates the co-inductio ...... s in primary human macrophages
@en
type
label
RIG-I mediates the co-inductio ...... s in primary human macrophages
@ast
RIG-I mediates the co-inductio ...... s in primary human macrophages
@en
prefLabel
RIG-I mediates the co-inductio ...... s in primary human macrophages
@ast
RIG-I mediates the co-inductio ...... s in primary human macrophages
@en
P2093
P2860
P1433
P1476
RIG-I mediates the co-inductio ...... s in primary human macrophages
@en
P2093
Eric Bartee
Gregory A Dekaban
Jingxin Cao
John W Barrett
Masmudur Rahman
Steve Werden
Timothy Irvine
Xiujuan Gao
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000099
P577
2008-07-11T00:00:00Z